1.The effect of short message service (SMS) reminder on adherence to standard care and glycemic control of adolescent patients with Type 1 Diabetes Mellitus.
Kristine Mae D. BETANSOS ; Ignace Claire P. GAMALLO ; Lorna R. ABAD
The Philippine Children’s Medical Center Journal 2025;21(2):32-48
BACKGROUND: Adolescence was associated with suboptimal diabetes control. Studies supporting the use of mobile technology to improve glycemic control and adherence to treatment had mixed results.
OBJECTIVES: This study aimed to evaluate the effect of SMS reminders on improving glycemic control in adolescents with Type 1 Diabetes Mellitus (T1DM)
METHODOLOGY: A randomized control study among adolescents with poorly controlled type 1 diabetes mellitus was done. Data were processed from 56 out of 64 subjects who were randomized into control (N=29) who received standard of care and SMS group (N=27), who received standard of care and a daily SMS reminder regarding diabetes self-care for 12 weeks. An adherence form was answered by all participants and glycosylated hemoglobin (HbA1c) before and after intervention was compared.
RESULTS: HbA1c did not significantly differ between SMS and control groups after 12 weeks of intervention (SMS 9.98+2.12 vs control 10.54+2.13, p value of 0.305). Post intervention, there was no significant difference between SMS and control group in terms of adherence to insulin injection (no p value), blood glucose (BG) monitoring (p value 0.106), and diabetic diet (p value 0.803). However, adherence on exercise was significantly higher among control group than SMS group (p value 0.003).
CONCLUSION: A 12-week SMS intervention reminder in adolescents with type 1 diabetes mellitus did not significantly improve glycemic control and adherence to standard of care (insulin injection, blood glucose monitoring, diet and exercise).
RECOMMENDATION: Future researches could include a bigger study population and longer duration of intervention. Other forms of mobile technology could also be used as a form of reminder.
Human ; Male ; Female ; Child: 6-12 Yrs Old ; Adolescent: 13-18 Yrs Old ; Diabetes Mellitus ; Diabetes Mellitus, Type 1 ; Text Messaging ; Glycated Hemoglobin ; Therapeutics ; Technology ; Standard Of Care ; Self Care
2.Real-world efficacy of baricitinib among patients with severe and critical COVID-19 pneumonia admitted in Ospital ng Makati from December 2020 to May 2021: A case-control study
Aldrin J. Corañ ; ez ; Ryan Paul Fernandez ; Maria Czarina Poquiz ; Edlyn John Santos ; Evan Vista
Philippine Journal of Internal Medicine 2024;62(2):77-82
Background:
Management of COVID--19 patients during surges have been a challenge as hospitals have to deal with staff,
room, and medication shortages. Among these medications is tocilizumab which is given to patients with severe/critical
conditions. In Ospital ng Makati, patients are given baricitinib as alternative immunomodulator to prevent possible cytokine
storm during tocilizumab shortages. The current recommendation for baricitinib is to give it in addition to dexamethasone
and remdesivir for hospitalized COVID-19 patients requiring low to high-flow oxygen, and non-invasive ventilation.
However, there is not enough evidence to recommend it as an alternative to tocilizumab in COVID--19 patients. This study
aims to find out the real-world efficacy of baricitinib in addition to standard of care among admitted patients with severe
COVID-19 pneumonia admitted in Ospital ng Makati.
Methods:
This is a retrospective, case control study that reviewed records of adult patients admitted at Ospital ng Makati
from December 2020 to May 2021 due to severe COVID-19. Patients who were given standard of care was compared to
those who were given baricitinib by measuring the duration of clinical improvement, in-hospital all-cause mortality, number
of hospital stay, and progression to acute respiratory distress syndrome (ARDS) and need for mechanical ventilator.
Results:
The use of baricitinib led to a faster improvement time (10 vs 12 days) however did not reach level of significance (p=0.069). There was also no significant difference in the mortality, number of hospital days, and progression to ARDS between the two groups.
Conclusion
There is not enough evidence to recommend baricitinib as an alternative to tocilizumab in patients with severe
COVID--19 infection.
COVID-19
;
Standard of Care
3.Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.
Shiqi MAO ; Libo LUO ; Shuo YANG ; Yan WANG ; Fei ZHOU ; Jia YU ; Bin CHEN ; Guanghui GAO ; Xuefei LI ; Chao ZHAO ; Lei CHENG ; Yiwei LIU ; Wanying WANG ; Keyi JIA ; Chuchu SHAO ; Xinyu LIU ; Xiaoxia CHEN ; Chunxia SU ; Caicun ZHOU ; Fengying WU ; Shengxiang REN
Chinese Medical Journal 2023;136(7):848-850
4.Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery
Jie YANG ; Jiaxin YANG ; Dongyan CAO ; Keng SHEN ; Jiabin MA ; Fuquan ZHANG
Journal of Gynecologic Oncology 2020;31(2):16-
OBJECTIVE: To compare patient survival outcomes between completion hysterectomy and conventional surveillance in locally advanced adenocarcinoma of the cervix after concurrent chemoradiotherapy (CCRT).METHODS: Patients with adenocarcinoma of the cervix after CCRT were identified in a tertiary academic center database from 2004 to 2018. Patients received completion hysterectomy or surveillance after CCRT. We compared the progression-free survival (PFS) and overall survival (OS) between the patients with or without adjuvant hysterectomy. Surgery features, operative complications, and pathologic characteristics were documented. Patient outcomes were also analyzed according to clinicopathologic factors.RESULTS: A total of 78 patients were assigned to completion surgery and 97 to surveillance after CCRT. The PFS was better in the surgery group compared to the CCRT only group, at 3 years the PFS rates were 68.1% and 45.2%, respectively (hazard ratio [HR]=0.46; 95% confidence interval [CI]=0.282–0.749; p=0.002). Adjuvant surgery was also associated with a higher rate of OS (HR=0.361; 95% CI=0.189–0.689; p=0.002), at 3 years, 87.9% and 67%, respectively. Tumor stage, size, lymph-vascular space invasion (LVSI), lymphadenopathy were associated with PFS but not with OS. Hysterectomy specimens revealed 64.1% (50/78) of the patients had pathologic residual tumor. Patients age less than 60, tumor size over 4 cm, stage IIB and persistent residual disease after CCRT were most likely to benefit from hysterectomy. Hysterectomy was associated with a lower rate of locoregional recurrence but did not reach statistical significance (5.13% vs. 13.5%, p=0.067).CONCLUSION: Completion hysterectomy after CCRT was associated with better survival outcome compared with the current standard of care.
Adenocarcinoma
;
Cervix Uteri
;
Chemoradiotherapy
;
Disease-Free Survival
;
Female
;
Humans
;
Hysterectomy
;
Lymphatic Diseases
;
Neoplasm, Residual
;
Recurrence
;
Standard of Care
;
Uterine Cervical Neoplasms
5.Penile Reconstructive Surgery in Peyronie Disease: Challenges in Restoring Normal Penis Size, Shape, and Function
The World Journal of Men's Health 2020;38(1):1-8
standard of care, they pose considerable risks and require prolonged postoperative rehabilitation. Obtaining proper informed consent and establishing realistic outcome expectations are imperative for successful postoperative outcomes.]]>
Congenital Abnormalities
;
Contracture
;
Erectile Dysfunction
;
Humans
;
Informed Consent
;
Male
;
Penile Induration
;
Penile Prosthesis
;
Penis
;
Rehabilitation
;
Sensation
;
Standard of Care
;
Surgeons
;
Transplants
6.Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
Journal of Breast Cancer 2019;22(1):149-152
No abstract available.
Breast Neoplasms
;
Breast
;
Humans
;
Neoadjuvant Therapy
;
Standard of Care
7.Alternative Transcarotid Approach for Endovascular Treatment of Acute Ischemic Stroke Patients: A Case Series
Hanna STYCZEN ; Daniel BEHME ; Amelie Carolina HESSE ; Marios Nikos PSYCHOGIOS
Neurointervention 2019;14(2):131-136
PURPOSE: Mechanical thrombectomy has become the standard of care for acute stroke caused by large vessel occlusion. As more patients are treated endovascularly, the number of older patients with tortuous vessels has risen. In these patients, catheterizing the internal carotid artery via a transfemoral approach can be very difficult or even impossible. Therefore, in selected patients, alternative strategies to the transfemoral approach have to be applied. MATERIALS AND METHODS: We report a case series of six patients undergoing mechanical thrombectomy via a combined transfemoral and transcarotid approach. Puncture of the carotid artery was conducted using roadmap guidance after an unsuccessful transfemoral attempt. Technical aspects and outcomes with this alternative approach were analyzed. RESULTS: Direct puncture of the carotid artery was achieved in five out of six patients (83%). In three out of six patients (50%), revascularization (modified Thrombolysis in Cerebral Infarction score ≥2b) was restored. No complications related to endovascular therapy were documented. One patient showed good neurological outcome (modified Rankin Scale [mRS] 5 at admission, mRS 1 at discharge). CONCLUSION: A combined transfemoral/transcarotid approach can be an alternative vascular access in patients with problematic vessel anatomy.
Carotid Arteries
;
Carotid Artery, Internal
;
Catheters
;
Cerebral Infarction
;
Humans
;
Punctures
;
Standard of Care
;
Stroke
;
Thrombectomy
8.2019 Update of the Korean Clinical Practice Guidelines of Stroke for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke
Sang Bae KO ; Hong Kyun PARK ; Byung Moon KIM ; Ji Hoe HEO ; Joung Ho RHA ; Sun U KWON ; Jong S KIM ; Byung Chul LEE ; Sang Hyun SUH ; Cheolkyu JUNG ; Hae Woong JEONG ; Dong Hun KANG ; Hee Joon BAE ; Byung Woo YOON ; Keun Sik HONG
Neurointervention 2019;14(2):71-81
Endovascular recanalization therapy (ERT) has been a standard of care for patients with acute ischemic stroke due to large artery occlusion (LAO) within 6 hours after onset, since five landmark ERT trials conducted by 2015 demonstrated its clinical benefit. Recently, two randomized clinical trials demonstrated that ERT, even in the late time window of up to 16 hours or 24 hours after last known normal time, improved the outcome of patients who had a target mismatch, defined as either clinical-core mismatch or perfusion-core mismatch, which prompted the update of national guidelines in several countries. Accordingly, to provide evidence-based and up-to-date recommendations for ERT in patients with acute LAO in Korea, the Clinical Practice Guidelines Committee of the Korean Stroke Society decided to revise the previous Korean Clinical Practice Guidelines of Stroke for ERT. For this update, the members of the writing group were appointed by the Korean Stroke Society and the Korean Society of Interventional Neuroradiology. After thoroughly reviewing the updated evidence from two recent trials and relevant literature, the writing members revised recommendations, for which formal consensus was achieved by convening an expert panel composed of 45 experts from the participating academic societies. The current guidelines are intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT. The ultimate decision for ERT in a particular patient must be made in light of circumstances specific to that patient.
Arteries
;
Caregivers
;
Cerebral Infarction
;
Consensus
;
Health Personnel
;
Humans
;
Korea
;
Mechanical Thrombolysis
;
Reperfusion
;
Standard of Care
;
Stroke
;
Writing
9.Utilization of digital technology in fabricating mandibular implant overdenture for skeletal class II edentulous patient: A case report
Yeun Yi LEE ; Seoungjin HONG ; Janghyun PAEK ; Kwantae NOH ; Kung Rock KWON
The Journal of Korean Academy of Prosthodontics 2019;57(4):364-373
Unlike class I patients, skeletal class II patients have unstable occlusion thus leading to instability of mandibular complete denture. Therefore, mandibular implant overdenture has been the standard of care due to its advantages in stability and retention. The types of attachments can be divided into two categories: solitary and bar type. The indications vary between two categories. In this clinical report, digital technology was utilized from the implant planning to the choice of appropriate attachment. Implants were placed at the desired location as previously planned in terms of angle and depth. Maxillary removable partial denture and mandibular implant overdenture are expected to have fair prognosis.
Denture, Complete
;
Denture, Overlay
;
Denture, Partial, Removable
;
Humans
;
Prognosis
;
Spatial Analysis
;
Standard of Care
10.Glucose Management Using Continuous Glucose Monitors
Journal of Korean Diabetes 2019;20(1):42-46
In the Diabetes Care Guidelines of the Korean Diabetes Association in 2015, the use of continuous glucose monitoring in patients with type 1 diabetes who undergo multiple insulin therapy or insulin pump therapy is helpful in controlling blood sugar and monitoring blood glucose level when fluctuation is high or hypoglycemia is frequent. Recently, the American Diabetes Association published in the 2019 Standard of Care in Diabetes in the new diabetes technology part the criteria for use and methods of the continuous blood glucose meter. Continuous and real-time blood glucose meters emphasize the importance of education prior to use. In particular, the real-time blood glucose meter is a useful device for prevention of hypoglycemia in type 1 diabetes in children and adults. The purpose of this study is to summarize the contents of the continuous blood glucose measurement part of the 2019 Standard of Care in Diabetes.
Adult
;
Blood Glucose
;
Child
;
Diabetes Mellitus
;
Education
;
Glucose
;
Humans
;
Hypoglycemia
;
Insulin
;
Standard of Care


Result Analysis
Print
Save
E-mail